|
US7067644B2
(en)
|
2000-12-05 |
2006-06-27 |
Wisconsin Alumni Research Foundation |
Double transposition methods for manipulating nucleic acids
|
|
US7064246B2
(en)
|
2001-05-01 |
2006-06-20 |
Macrae Amy F |
Use of transposable elements for altering gene expression
|
|
US7262056B2
(en)
|
2001-11-08 |
2007-08-28 |
Mirus Bio Corporation |
Enhancing intermolecular integration of nucleic acids using integrator complexes
|
|
AU2002360986A1
(en)
|
2001-12-20 |
2003-07-09 |
Sungene Gmbh And Co. Kgaa |
Methods for the transformation of vegetal plastids
|
|
US20080008687A1
(en)
|
2003-02-10 |
2008-01-10 |
Max-Delbruck-Centrum Fur Molekulare Medizin (Mdc) |
Transposon-Based Targeting System
|
|
DK1594973T3
(da)
|
2003-02-10 |
2012-02-13 |
Max Delbrueck Centrum |
Transposonbaseret målretningssystem
|
|
GB2403475B
(en)
|
2003-07-01 |
2008-02-06 |
Oxitec Ltd |
Stable integrands
|
|
US8071364B2
(en)
|
2003-12-24 |
2011-12-06 |
Transgenrx, Inc. |
Gene therapy using transposon-based vectors
|
|
US20060252140A1
(en)
*
|
2005-04-29 |
2006-11-09 |
Yant Stephen R |
Development of a transposon system for site-specific DNA integration in mammalian cells
|
|
EP2392657B1
(en)
|
2005-07-05 |
2013-09-25 |
The Chemo-Sero-Therapeutic Research Institute |
Modified transposon vector and its use
|
|
EP2160461B1
(en)
|
2007-07-04 |
2012-08-08 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Hyperactive variants of the transposase protein of the transposon system sleeping beauty
|
|
US8524979B2
(en)
|
2008-04-14 |
2013-09-03 |
National Taiwan University |
Termination of transgene expression via transposon-mediated break
|
|
US20110239315A1
(en)
|
2009-01-12 |
2011-09-29 |
Ulla Bonas |
Modular dna-binding domains and methods of use
|
|
US8399643B2
(en)
|
2009-02-26 |
2013-03-19 |
Transposagen Biopharmaceuticals, Inc. |
Nucleic acids encoding hyperactive PiggyBac transposases
|
|
ES2697535T3
(es)
|
2009-06-11 |
2019-01-24 |
Inter Univ Research Institute Corporation Research Organization Of Information And Systems |
Procedimiento para la producción de proteína
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
US20130017978A1
(en)
|
2011-07-11 |
2013-01-17 |
Finnzymes Oy |
Methods and transposon nucleic acids for generating a dna library
|
|
CN103946952A
(zh)
|
2011-09-16 |
2014-07-23 |
宾夕法尼亚大学董事会 |
用于治疗癌症的rna改造的t细胞
|
|
DK2825190T3
(en)
|
2012-03-15 |
2017-02-27 |
Cellectis |
REPEAT VARIABLE DIRESTS FOR TARGETING NUCLEOTIDES
|
|
PT2692865E
(pt)
|
2012-07-30 |
2015-02-06 |
Nbe Therapeutics Llc |
Identificação mediada por transposição de proteínas funcionais ou de ligação específicas
|
|
FI3536797T3
(fi)
|
2013-02-01 |
2023-03-23 |
Selexis Sa |
Siirtogeenin tehostettu ilmentäminen ja prosessointi
|
|
EP3783098A1
(en)
|
2013-05-14 |
2021-02-24 |
Board Of Regents, The University Of Texas System |
Human application of engineered chimeric antigen receptor (car) t-cells
|
|
AU2015234242B2
(en)
|
2014-03-21 |
2020-09-24 |
Children's Medical Research Institute |
Stable gene transfer to proliferating cells
|
|
CN103981204B
(zh)
|
2014-03-24 |
2016-05-04 |
上海海洋大学 |
一种有活性的金鱼Tgf2转座子重组转座酶蛋白的表达方法
|
|
DK3129487T3
(da)
|
2014-04-09 |
2020-11-30 |
Dna Twopointo Inc |
Forbedrede nukleinsyrekonstruktioner til eukaryot genekspression
|
|
US20170107541A1
(en)
|
2014-06-17 |
2017-04-20 |
Poseida Therapeutics, Inc. |
A method for directing proteins to specific loci in the genome and uses thereof
|
|
JP2017534295A
(ja)
|
2014-09-29 |
2017-11-24 |
ザ ジャクソン ラボラトリー |
エレクトロポレーションによる遺伝子改変哺乳動物の高効率ハイスループット生成
|
|
EP3018200A1
(en)
|
2014-11-07 |
2016-05-11 |
Fondazione Matilde Tettamanti e Menotti de Machi Onlus |
Improved method for the generation of genetically modified cells
|
|
JP2018513681A
(ja)
|
2015-03-31 |
2018-05-31 |
エクセリゲン サイエンティフィック, インコーポレイテッドExeligen Scientific, Inc. |
細胞または生物のゲノムへのＤＮＡ配列の標的化組み込みのためのＣａｓ９レトロウイルスインテグラーゼおよびＣａｓ９レコンビナーゼ系
|
|
CN107980059B
(zh)
|
2015-04-13 |
2022-11-11 |
美克斯细胞有限公司 |
用于修饰基因组dna的方法和组合物
|
|
WO2016191618A1
(en)
|
2015-05-27 |
2016-12-01 |
Jianbiao Zheng |
Methods of inserting molecular barcodes
|
|
US11473082B2
(en)
|
2015-06-17 |
2022-10-18 |
Poseida Therapeutics, Inc. |
Compositions and methods for directing proteins to specific loci in the genome
|
|
WO2017046259A1
(en)
|
2015-09-16 |
2017-03-23 |
Ethris Gmbh |
Improved transposon system for gene delivery
|
|
ES3063691T3
(en)
|
2015-09-22 |
2026-04-20 |
Univ Wuerzburg J Maximilians |
A method for high level and stable gene transfer in lymphocytes
|
|
CN105154473B
(zh)
|
2015-09-30 |
2019-03-01 |
上海细胞治疗研究院 |
一种高效安全的转座子整合系统及其用途
|
|
EP4289944A3
(en)
|
2015-10-08 |
2024-03-13 |
National University Corporation Tokai National Higher Education and Research System |
Method for preparing genetically-modified t cells which express chimeric antigen receptor
|
|
KR102249982B1
(ko)
|
2015-12-14 |
2021-05-11 |
게놈프론티어 테라퓨틱스 인코포레이티드 |
트랜스포존 시스템, 이를 포함한 키트, 및 이들의 용도
|
|
WO2017123758A1
(en)
|
2016-01-12 |
2017-07-20 |
Seqwell, Inc. |
Compositions and methods for sequencing nucleic acids
|
|
US20190048085A1
(en)
|
2016-02-25 |
2019-02-14 |
Cell Medica Switzerland Ag |
Modified cells for immunotherapy
|
|
CN109312361A
(zh)
|
2016-02-26 |
2019-02-05 |
波赛伊达治疗学股份有限公司 |
转座子系统及应用方法
|
|
EP3219800A1
(en)
|
2016-03-15 |
2017-09-20 |
Max-Delbrück-Centrum Für Molekulare Medizin |
A transposon-based transfection system for primary cells
|
|
KR20190006952A
(ko)
|
2016-03-31 |
2019-01-21 |
라이언 티씨알 피티이. 리미티드 |
외인성 바이러스-특이적 t 세포 수용체 (tcr)를 발현하는 비-활성화된 t 세포
|
|
EP3452082A1
(en)
|
2016-05-04 |
2019-03-13 |
Fred Hutchinson Cancer Research Center |
Cell-based neoantigen vaccines and uses thereof
|
|
CN107523547A
(zh)
|
2016-06-20 |
2017-12-29 |
上海细胞治疗研究院 |
一种高效稳定表达抑制性抗体的car‑t细胞及其用途
|
|
CN107523548A
(zh)
|
2016-06-20 |
2017-12-29 |
上海细胞治疗研究院 |
一种高效稳定表达抗体的t细胞及其用途
|
|
CN107523549A
(zh)
|
2016-06-20 |
2017-12-29 |
上海细胞治疗研究院 |
一种高效稳定表达激活型抗体的car‑t细胞及其用途
|
|
CN107523545A
(zh)
|
2016-06-20 |
2017-12-29 |
上海细胞治疗研究院 |
一种高效稳定表达抗体的杀伤性细胞及其用途
|
|
KR20190031306A
(ko)
|
2016-07-21 |
2019-03-25 |
맥스시티 인코포레이티드 |
게놈 dna를 변경하기 위한 방법 및 조성물
|
|
WO2018031683A1
(en)
|
2016-08-09 |
2018-02-15 |
President And Fellows Of Harvard College |
Programmable cas9-recombinase fusion proteins and uses thereof
|
|
WO2018042776A1
(ja)
|
2016-08-30 |
2018-03-08 |
国立大学法人九州大学 |
Ｄｎａ結合タンパク質の結合領域の近傍に所望のｄｎａ断片を挿入する方法
|
|
WO2018057779A1
(en)
|
2016-09-23 |
2018-03-29 |
Jianbiao Zheng |
Compositions of synthetic transposons and methods of use thereof
|
|
CA3036926C
(en)
|
2016-09-30 |
2022-05-31 |
Poseida Therapeutics, Inc. |
Modified stem cell memory t cells, methods of making and methods of using same
|
|
US11793833B2
(en)
|
2016-12-02 |
2023-10-24 |
Juno Therapeutics, Inc. |
Engineered B cells and related compositions and methods
|
|
JP7275043B2
(ja)
|
2016-12-16 |
2023-05-17 |
ビー－モーゲン・バイオテクノロジーズ，インコーポレーテッド |
増大したｈＡＴファミリートランスポゾン媒介遺伝子導入ならびに関連する組成物、システムおよび方法
|
|
EP3568474A1
(en)
|
2017-01-10 |
2019-11-20 |
Intrexon Corporation |
Modulating expression of polypeptides via new gene switch expression systems
|
|
WO2018140644A1
(en)
|
2017-01-25 |
2018-08-02 |
Musc Foundation For Research Development |
Modified t cells and uses thereof
|
|
CA3104288A1
(en)
|
2018-06-21 |
2019-12-26 |
B-Mogen Biotechnologies, Inc. |
Enhanced hat family transposon-mediated gene transfer and associated compositions, systems, and methods
|